The treatment of spasticity by intrathecal administration of baclofen: a preliminary personal experience
- PMID: 7931643
The treatment of spasticity by intrathecal administration of baclofen: a preliminary personal experience
Abstract
The administration of baclofen, a GABAb agonist, by direct infusion into the CSF by means of a programmable device, may avoid the undesired side effects of the oral administration of both the same and other antispastic drugs while giving a marked reduction of spasticity. The preliminary results on 12 patients show the total efficacy of this procedure in reducing spasticity markedly.